vasod2 versr2
Name
verir2
Label
Immediate-Release Verapamil (Sleep Heart Health Study Visit Two (SHHS2))
Description

Participant taking IMMEDIATE-RELEASE VERAPAMIL within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
arrythmia high blood pressure htn hypertension medication_form_shhs
Immediate-Release Verapamil (Sleep Heart Health Study Visit Two (SHHS2)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,604 -
Yes - - 16 -
Unknown - - 460 -
Immediate-Release Verapamil (Sleep Heart Health Study Visit Two (SHHS2)) vs Gender of the participant
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,654 1,950 3,604
Yes 7 9 16
Unknown 200 260 460
Immediate-Release Verapamil (Sleep Heart Health Study Visit Two (SHHS2)) vs Race of the participant
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,150 238 216 3,604
Yes 12 4 - 16
Unknown 425 14 21 460